FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Panacea Biotec Limited)

View source ↗

Summary

FDA approves Panacea Biotec Limited's rizatriptan benzoate Original Application (ANDA) for the acute treatment of migraine, adding a generic option.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)